The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab)

FHS
April 18, 2024
12:54 pm

The U.S. Pharmacopeia (USP) and Mestrelab Research, S.L. (Mestrelab), are pleased to announce they have entered into a collaboration to deliver USP-ID, through Mestrelab’s Mnova platform.

‘New Gold Standard’ for Previously Untreated CLL

SAN DIEGO — A time-limited, targeted combination significantly improved survival compared with chemoimmunotherapy in fit chronic lymphocytic leukemia (CLL) patients who met criteria for starting

December 11, 2023

WuXi in ‘early stages’ of CGT business review; Lonza exec becomes AGC Bio CEO

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. WuXi AppTec is in the early

November 1, 2024

Veracyte to buy C2i Genomics for up to $95M, includes $70M upfront

In announcing plans on Monday to pay up to $95 million for C2i Genomics, Veracyte is betting that it will expand further along the cancer

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.